Penumbra (PEN) Stock Price, News, Quotes-Moomoo

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

BTIG Maintains Penumbra(PEN.US) With Buy Rating, Maintains Target Price $308
Moomoo NewsFeb 25 05:33 ET · Ratings
Truist Financial Maintains Penumbra(PEN.US) With Buy Rating, Maintains Target Price $325
Moomoo NewsFeb 24 22:32 ET · Ratings
Truist Financial Sticks to Their Buy Rating for Penumbra (PEN)
TipRanksFeb 24 21:37 ET · Ratings
Stifel Maintains Penumbra(PEN.US) With Buy Rating, Raises Target Price to $301
Moomoo NewsFeb 24 21:32 ET · Ratings
Analysts Offer Insights on Healthcare Companies: Trevi Therapeutics (TRVI), Astrana Health (ASTH) and Penumbra (PEN)
TipRanksFeb 24 21:10 ET · Ratings
Penumbra (PEN) Receives a Buy From Leerink Partners
TipRanksFeb 23 06:15 ET · Ratings

Comments

Movers and Shakers

Feb 19 07:25

Columns Today's Pre-Market Movers and Top Ratings | MCI, WBA, PEN and More

Morning Movers
Gapping Up
$Super Micro Computer (SMCI.US)$ shares surged 8.2% in premarket trading after the company projected significant sales growth in 2026, driven by increased demand for AI servers.
$Walgreens Boots Alliance (WBA.US)$ shares jumped 14% after reports that a potential deal to sell the company to private equity firm Sycamore Partners may be back on the table.
$NVIDIA (NVDA.US)$ shares edged up 0.4% despite Presid...

33

10

19

Moomoo AI

Feb 22, 2024 11:42

Despite the high P/S ratio, shareholders are holding onto Penumbra's stocks due to its strong future revenue prospects. The strong revenue forecasts are expected to keep the share price buoyant unless the analysts have significantly misjudged the company's potential.

Penumbra, Inc.'s (NYSE:PEN) Earnings Haven't Escaped The Attention Of Investors

Chatterbox Moo

Nov 21, 2023 04:20

Columns Medical-device Stock Selloff Caused by Ozempic Fears Has Gone Too Far—Now They're Rebounding

A new generation of highly effective weight-loss and diabetes drugs known as GLP-1s has led Wall Street to spell doom for companies that have profited from obesity problem. However, the reaction on Wall Street has been extreme, creating opportunities for cooler heads, some analysts and investors say.
To be sure, drugs such as $Novo-Nordisk A/S (NVO.US)$'s Ozempic and Wegovy, and Eli Lilly's Mounjaro have p...

11

Moomoo AI

Nov 9, 2023 05:00

Penumbra's earnings outlook could be brighter than reflected in the statutory profit due to one-off items. The company's profitability this year shows a good sign after previous losses.

The Strong Earnings Posted By Penumbra (NYSE:PEN) Are A Good Indication Of The Strength Of The Business

Moomoo AI

Nov 3, 2023 12:00

Penumbra's low ROE and declining net income over five years hint at sub-par performance. The earnings' decline, despite profit retention, could imply a struggling business or high payout ratio. Analyst estimates, however, foresee a better earnings growth rate.

Is Penumbra, Inc.'s (NYSE:PEN) Recent Price Movement Underpinned By Its Weak Fundamentals?

PEN Penumbra

Trade Overview

Capital Trend

News

Comments

Trending Stocks